Cardiovascular Device Update articles from November 2007

Cardiovascular Device Update archives from November 2007

As to innovation in cardio care devices trump drugs and diagnostics.
November 1, 2007... As to innovation in cardio care DEVICES! trump drugs and diagnostics By MICHAEL SIMONSEN Cardiovascular Device Update Contributing Editor and DON LONG Cardiovascular Device Update Executive Editor ORLANDO,...

Pharma developments.
November 1, 2007... Pharma developments STITCH algorithm improves compliance, serves to reduce BP A CDU Staff Report It's a rather famous fact that patients frequently don't take the drugs they're prescribed and don't even have them filled at the...

Medtronic recalls leads, St. Jude also tainted by fracture problem.
November 1, 2007... Medtronic recalls leads, St. Jude also tainted by fracture problem A CDU Staff Report As surely as night follows day, the lawsuits began lining up against. Medtronic (Minneapolis) shortly after the reports of the company's recall of...

Endeavor DES gets panel thumbs-up.
November 1, 2007... 2nd-generation devices on the way Endeavor DES gets panel thumbs-up By MARK McCARTY CDU Washington Editor GAITHERSBURG, Maryland — The era of second-generation drug-eluting stent (DES) technology moved one step closer...

Panel says 'no' to non-RCTs, this time for carotid stenting.
November 1, 2007... Panel says 'no' to non-RCTs, this time for carotid stenting By MARK McCARTY CDU Washington Editor GAITHERSBURG, Maryland — Largely at the prodding of industry, FDA has pondered whether it should grant device makers greater...

For Europe market, 'viva la difference' and device novelty.
November 1, 2007... For Europe market, 'viva la difference' and device novelty By JOHN BROSKY CDU European Editor PARIS — On one level at least, Europe is only an idea. It has a flag and an anthem, but no constitution nor a mandate to regulate...

International report.
November 1, 2007... International report Direct Flow closes B $27M round, begins European trial Direct Flow Medical (Santa Rosa, California), a company developing a minimally invasive implant to treat patients with heart valve disease, reported completing...

Business developments.
November 1, 2007... Business developments Boston Sci in 13% staff cuts and plan for restructuring By HOLLAND JOHNSON CDU Managing Editor In another move designed to deal with big debt and stagnating device sales, Boston Scientific (Natick,...

Deals.(Company overview)
November 1, 2007... Deals • Ariad Pharmaceuticals (Cambridge, Massachusetts) reported that it has entered a nonexclusive license agreement with Icon Medical, an emerging cardiovascular medical device company, to develop drug-eluting stents that deliver...

ImaRx, Philips develop microbubble technology for ischemic stroke.
November 1, 2007... ImaRx, Philips develop microbubble technology for ischemic stroke By LYNN YOFFEE CDU Staff Writer ImaRx Therapeutics (Tucson, Arizona) and Royal Philips Electronics (Amsterdam, the Netherlands) reported a new research alliance...

Agreements/Contracts.
November 1, 2007... Agreements/Contracts • Alpha Innotech (AI; San Leandro, California), a provider of bioanalytical systems for drug discovery and life science research, reported a product development and OEM supply agreement with R&C Biogenius (Los...

Market/technology updates.
November 1, 2007... Market/technology updates Study data favors bypass surgery over PCI/stenting By OMAR FORD CDU Staff Writer In today's microwave society, where results are sometimes wanted yesterday, coronary stent procedures have proven to be...

Personnel file.
November 1, 2007... Personnel file • Donald Wood has been named VP of operations for Abaxis (Union City, California), a manufacturer of portable blood analysis systems. Wood most recently served as VP of operations at Cholestech. • Wayne...

Product pipeline.
November 1, 2007... Product pipeline CVRx receives CE mark for its Rheos hypertension therapy CVRx (Minneapolis) last month received the CE mark for its Rheos Baroreflex Hypertension Therapy System, which it said is the only implantable device designed to...

At press time … Cardiogenesis wins approval for PEARL TMR hand piece.
November 1, 2007... At press time … Cardiogenesis wins approval for PEARL TMR hand piece Cardiogenesis (Irvine, Califonrnia), a developer of surgical products for transmyocardial revascularization (TMR) reported FDA approval of its PEARL (Port Enabled...